Publications by authors named "Dominik Chraniuk"

Claim this Profile
P
Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial.
Raajit K Rampal, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Meletios Athanasios Dimopoulos, Vania T M Hungria, Atanas Radinoff, Sosana Delimpasi, Gabor Mikala, Dominik Chraniuk

Lancet Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of miRSNPs associated with the risk of multiple myeloma.
Angelica Macauda, Diego Calvetti, Giuseppe Maccari, Kari Hemminki, Asta Försti, Dominik Chraniuk

Int J Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis